Bellicum Pharmaceuticals Inc - ESG Rating & Company Profile powered by AI
The page includes a questions and answers table about Bellicum Pharmaceuticals Inc. Jump to the bottom of this page for potential risks for Bellicum Pharmaceuticals Inc based on industry, geography and size. Other companies in the scoring industry group for Bellicum Pharmaceuticals Inc are shown below.
Bellicum Pharmaceuticals Inc in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 4.9; made up of an environmental score of 4.0, social score of 2.7 and governance score of 8.0.
4.9
Medium ImpactEnvironmental
Social
Governance

Peer Group Comparison
Rank | Company | SDG Transparency Score ⓘ | Performance |
---|---|---|---|
1 | Caladrius Biosciences Inc | 8.0 | High |
1 | Can Fite Biopharma Ltd | 8.0 | High |
744 | Sopharma AD | 5.0 | High |
744 | vTv Therapeutics Inc | 5.0 | High |
764 | Bellicum Pharmaceuticals Inc | 4.9 | High |
764 | BetterLife Pharma Inc | 4.9 | High |
764 | Acerus Pharmaceuticals Corporation | 4.9 | High |
... | ... | ... | |
1970 | Zyden Gentec Ltd | 0.0 | Low |
1970 | iNtRON Biotechnology Inc | 0.0 | Low |
... | ... | ... |

Frequently Asked Questions
Does Bellicum Pharmaceuticals Inc have an accelerator or VC vehicle to help deliver innovation?
Does Bellicum Pharmaceuticals Inc disclose current and historical energy intensity?
Does Bellicum Pharmaceuticals Inc report the average age of the workforce?
Does Bellicum Pharmaceuticals Inc reference operational or capital allocation in relation to climate change?
Does Bellicum Pharmaceuticals Inc disclose its ethnicity pay gap?
Does Bellicum Pharmaceuticals Inc disclose cybersecurity risks?
Does Bellicum Pharmaceuticals Inc offer flexible work?
Does Bellicum Pharmaceuticals Inc have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Does Bellicum Pharmaceuticals Inc disclose the number of employees in R&D functions?
Does Bellicum Pharmaceuticals Inc conduct supply chain audits?
Does Bellicum Pharmaceuticals Inc disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Is there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Does Bellicum Pharmaceuticals Inc conduct 360 degree staff reviews?
Does Bellicum Pharmaceuticals Inc disclose the individual responsible for D&I?
Does Bellicum Pharmaceuticals Inc disclose current and historical air emissions?
Is there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Is executive remuneration linked to climate performance?
Does the Board describe its role in the oversight of climate-related risks and opportunities?
Does Bellicum Pharmaceuticals Inc disclose current and / or historical scope 2 emissions?
Does Bellicum Pharmaceuticals Inc disclose water use targets?
Does Bellicum Pharmaceuticals Inc have careers partnerships with academic institutions?
Did Bellicum Pharmaceuticals Inc have a product recall in the last two years?
Does Bellicum Pharmaceuticals Inc disclose incidents of discrimination?
Does Bellicum Pharmaceuticals Inc allow for Work Councils/Collective Agreements to be formed?
Has Bellicum Pharmaceuticals Inc issued a profit warning in the past 24 months?
Does Bellicum Pharmaceuticals Inc disclose parental leave metrics?
Does Bellicum Pharmaceuticals Inc disclose climate scenario or pathway analysis?
Does Bellicum Pharmaceuticals Inc disclose current and / or historical scope 1 emissions?
Are Operating Expesnses linked to emissions reduction?
Does Bellicum Pharmaceuticals Inc disclose the pay ratio of women to men?
Does Bellicum Pharmaceuticals Inc support suppliers with sustainability related research and development?
Does Bellicum Pharmaceuticals Inc disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Does Bellicum Pharmaceuticals Inc reflect climate-related risks in its financial statements?
Is there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Is Bellicum Pharmaceuticals Inc involved in embryonic stem cell research?
Does Bellicum Pharmaceuticals Inc disclose GHG and Air Emissions intensity?
Does Bellicum Pharmaceuticals Inc disclose its waste policy?
Does Bellicum Pharmaceuticals Inc report according to TCFD requirements?
Does Bellicum Pharmaceuticals Inc disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Does Bellicum Pharmaceuticals Inc disclose energy use targets?
Does Bellicum Pharmaceuticals Inc disclose its Renewable Energy targets?

Are emissions metrics verified by STBi?

Does Bellicum Pharmaceuticals Inc have a policy relating to cyber security?
Have a different question?
Potential Risks for Bellicum Pharmaceuticals Inc
These potential risks are based on the size, segment and geographies of the company.
Bellicum Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing novel cellular immunotherapies for the treatment of hematological cancers and solid tumors in the United States and internationally. The company's clinical product candidates include BPX-601, an autologous GoCAR-T product candidate, which is in Phase 1/2 clinical trials for the treatment of solid tumors expressing the prostate stem cell antigen; and BPX-603, a dual-switch GoCAR-T product candidate that is in Phase 1/2 clinical trials to treat solid tumors that express the human epidermal growth factor receptor 2 antigens. Its clinical product candidates also include Rivo-cel, an allogeneic T cell product candidate intended to enhance outcomes in the treatment of leukemias, lymphomas, and inherited blood disorders. It has collaboration and license agreements with Adaptimmune Therapeutics plc; Agensys, Inc.; BioVec Pharma, Inc.; ARIAD Pharmaceuticals, Inc.; and Baylor College of Medicine. Bellicum Pharmaceuticals, Inc. was incorporated in 2004 and is headquartered in Houston, Texas.